Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.

MLA

Hao, Xiaoxin, et al. “Osteoprogenitor-GMP Crosstalk Underpins Solid Tumor-Induced Systemic Immunosuppression and Persists after Tumor Removal.” Cell Stem Cell, vol. 30, no. 5, May 2023, p. 648. EBSCOhost, https://doi.org/10.1016/j.stem.2023.04.005.

APA

Hao, X., Shen, Y., Chen, N., Zhang, W., Valverde, E., Wu, L., Chan, H. L., Xu, Z., Yu, L., Gao, Y., Bado, I., Michie, L. N., Rivas, C. H., Dominguez, L. B., Aguirre, S., Pingel, B. C., Wu, Y.-H., Liu, F., Ding, Y., … Zhang, X. H.-F. (2023). Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. Cell Stem Cell, 30(5), 648. https://doi.org/10.1016/j.stem.2023.04.005

Chicago

Hao, Xiaoxin, Yichao Shen, Nan Chen, Weijie Zhang, Elizabeth Valverde, Ling Wu, Hilda L Chan, et al. 2023. “Osteoprogenitor-GMP Crosstalk Underpins Solid Tumor-Induced Systemic Immunosuppression and Persists after Tumor Removal.” Cell Stem Cell 30 (5): 648. doi:10.1016/j.stem.2023.04.005.